Investigational Monkeypox Vaccines for Monkeypox

"As outlined in the requirements for participation, individuals must be between 18 and 65 years old to qualify."

"According to the information in clinicaltrials.gov, this research is currently looking for participants. It was initially posted on September 21st 2023 and recently revised on October 24th 2023."

"The safety of SSA-BNT166a is rated at a 1 due to the limited clinical research data regarding both its efficacy and overall security."

"Affirmative. Clinicaltrials.gov displays evidence that this medical investigation, which initially debuted on September 21st 2023, is still in search of participants. The trial requires 96 people to be recruited from two distinct sites."

"This medical trial is seeking to recruit 96 individuals with monkeypox aged 18-65. To qualify for the study, candidates must consent in writing and meet other conditions such as being of a certain age range (18-45 or 50-65 depending on group), demonstrate good health based on reported history and tests, agree not to enrol in another trial during this one, have an appropriate BMI between 18.5–30kg/m^2 and weigh at least 50 kg, either be previously vaccinated against smallpox before 1980 if over 45 years old or remain unvaccinated if under 46 years old, and finally pass HIV1/HIV"